132 related articles for article (PubMed ID: 38430625)
21. Hypoglycemia is common in children with cystic fibrosis and seen predominantly in females.
Haliloglu B; Gokdemir Y; Atay Z; Abali S; Guran T; Karakoc F; Ersu R; Karadag B; Turan S; Bereket A
Pediatr Diabetes; 2017 Nov; 18(7):607-613. PubMed ID: 27873431
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404
[TBL] [Abstract][Full Text] [Related]
23. Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.
Lek N; Acerini CL
Curr Diabetes Rev; 2010 Jan; 6(1):9-16. PubMed ID: 20034372
[TBL] [Abstract][Full Text] [Related]
24. Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system.
Schiaffini R; Brufani C; Russo B; Fintini D; Migliaccio A; Pecorelli L; Bizzarri C; Lucidi V; Cappa M
Eur J Endocrinol; 2010 Apr; 162(4):705-10. PubMed ID: 20071479
[TBL] [Abstract][Full Text] [Related]
25. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
[TBL] [Abstract][Full Text] [Related]
26. Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.
Scully KJ; Sherwood JS; Martin K; Ruazol M; Marchetti P; Larkin M; Zheng H; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Wexler DJ; Putman MS
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1444-e1454. PubMed ID: 34850006
[TBL] [Abstract][Full Text] [Related]
27. Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis-related diabetes.
Frost F; Dyce P; Nazareth D; Malone V; Walshaw MJ
J Cyst Fibros; 2018 Nov; 17(6):798-803. PubMed ID: 29885744
[TBL] [Abstract][Full Text] [Related]
28. Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status.
Lavie M; Fisher D; Vilozni D; Forschmidt R; Sarouk I; Kanety H; Hemi R; Efrati O; Modan-Moses D
Diabetes Res Clin Pract; 2015 Dec; 110(3):276-84. PubMed ID: 26508676
[TBL] [Abstract][Full Text] [Related]
29. Carbohydrate metabolism impairment in children and adolescents with cystic fibrosis.
Escudero García J; Martín Rivada Á; Uribe Posada A; Sanz Santiago V; Argente J; Martos-Moreno GÁ
Endocrinol Diabetes Nutr (Engl Ed); 2022 Oct; 69(8):576-583. PubMed ID: 36347795
[TBL] [Abstract][Full Text] [Related]
30. Delayed glucose peak and elevated 1-hour glucose on the oral glucose tolerance test identify youth with cystic fibrosis with lower oral disposition index.
Tommerdahl KL; Brinton JT; Vigers T; Cree-Green M; Zeitler PS; Nadeau KJ; Chan CL
J Cyst Fibros; 2021 Mar; 20(2):339-345. PubMed ID: 32928701
[TBL] [Abstract][Full Text] [Related]
31. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
Schmid K; Fink K; Holl RW; Hebestreit H; Ballmann M
J Cyst Fibros; 2014 Jan; 13(1):80-5. PubMed ID: 23809507
[TBL] [Abstract][Full Text] [Related]
32. Continuous glucose monitoring in a cystic fibrosis patient to predict pulmonary exacerbation?
Inman TB; Proudfoot JA; Lim M; Demeterco-Berggren C
J Cyst Fibros; 2017 Sep; 16(5):628-630. PubMed ID: 28625799
[TBL] [Abstract][Full Text] [Related]
33. [Continuous glucose monitoring system in the screening of glucose disorders in cystic fibrosis].
Martín-Frías M; Lamas Ferreiro A; Colino Alcol E; Alvarez Gómez MA; Yelmo Valverde R; Barrio Castellanos R
An Pediatr (Barc); 2009 Feb; 70(2):120-5. PubMed ID: 19217566
[TBL] [Abstract][Full Text] [Related]
34. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance.
Moreau F; Weiller MA; Rosner V; Weiss L; Hasselmann M; Pinget M; Kessler R; Kessler L
Horm Metab Res; 2008 Jul; 40(7):502-6. PubMed ID: 18415892
[TBL] [Abstract][Full Text] [Related]
35. Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline.
Chan CL; Vigers T; Pyle L; Zeitler PS; Sagel SD; Nadeau KJ
J Cyst Fibros; 2018 Nov; 17(6):783-790. PubMed ID: 29580828
[TBL] [Abstract][Full Text] [Related]
36. Glycemia and β-cell function before and after elexacaftor/tezacaftor/ivacaftor in youth and adults with cystic fibrosis.
Chan CL; Granados A; Moheet A; Singh S; Vigers T; Arbeláez AM; Yi Y; Hu S; Norris AW; Ode KL
J Clin Transl Endocrinol; 2022 Dec; 30():100311. PubMed ID: 36620757
[TBL] [Abstract][Full Text] [Related]
37. Continuous Glucose Monitoring as a Valuable Tool in the Early Detection of Diabetes Related to Cystic Fibrosis.
Gojsina B; Minic P; Todorovic S; Soldatovic I; Sovtic A
Front Pediatr; 2021; 9():659728. PubMed ID: 34307249
[No Abstract] [Full Text] [Related]
38. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria.
Yung B; Kemp M; Hooper J; Hodson ME
Thorax; 1999 Jan; 54(1):40-3. PubMed ID: 10343630
[TBL] [Abstract][Full Text] [Related]
39. Trajectories of oral glucose tolerance testing in cystic fibrosis.
Patel M; McCracken C; Daley T; Stecenko A; Linnemann R
Pediatr Pulmonol; 2021 May; 56(5):901-909. PubMed ID: 34402224
[TBL] [Abstract][Full Text] [Related]
40. Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program.
Sterescu AE; Rhodes B; Jackson R; Dupuis A; Hanna A; Wilson DC; Tullis E; Pencharz PB
J Pediatr; 2010 Apr; 156(4):613-7. PubMed ID: 19962154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
